Stem Cell Therapy for Autism
Open Access
- 27 June 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 5 (1), 30
- https://doi.org/10.1186/1479-5876-5-30
Abstract
Autism spectrum disorders (ASD) are a group of neurodevelopmental conditions whose incidence is reaching epidemic proportions, afflicting approximately 1 in 166 children. Autistic disorder, or autism is the most common form of ASD. Although several neurophysiological alterations have been associated with autism, immune abnormalities and neural hypoperfusion appear to be broadly consistent. These appear to be causative since correlation of altered inflammatory responses, and hypoperfusion with symptology is reported. Mesenchymal stem cells (MSC) are in late phases of clinical development for treatment of graft versus host disease and Crohn's Disease, two conditions of immune dysregulation. Cord blood CD34+ cells are known to be potent angiogenic stimulators, having demonstrated positive effects in not only peripheral ischemia, but also in models of cerebral ischemia. Additionally, anecdotal clinical cases have reported responses in autistic children receiving cord blood CD34+ cells. We propose the combined use of MSC and cord blood CD34+cells may be useful in the treatment of autism.Keywords
This publication has 126 references indexed in Scilit:
- Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From StrokeStroke, 2007
- The role of Toll‐like receptors in CNS response to microbial challengeJournal of Neurochemistry, 2006
- Insulin‐like growth factor‐1 is an endogenous mediator of focal ischemia‐induced neural progenitor proliferationEuropean Journal of Neuroscience, 2006
- Developing Granulocyte-Colony Stimulating Factor for the Treatment of Stroke: Current Status of Clinical TrialsStroke, 2006
- Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarctionLife Sciences, 2005
- Astrocyte activation and reactive gliosisGlia, 2005
- A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemiaTransfusion and Apheresis Science, 2004
- Oxidized Low-Density Lipoprotein Is Present in Astrocytes Surrounding Cerebral Infarcts and Stimulates Astrocyte Interleukin-6 SecretionThe American Journal of Pathology, 2004
- RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 1998
- Myelin basic protein stimulates the proliferation of astrocytes: possible explanation for multiple sclerosis plaque formationBrain Research, 1985